Matthew Goff Investment Advisor, LLC Abb Vie Inc. Transaction History
Matthew Goff Investment Advisor, LLC
- $575 Million
- Q3 2025
A detailed history of Matthew Goff Investment Advisor, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Matthew Goff Investment Advisor, LLC holds 17,561 shares of ABBV stock, worth $4.01 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
17,561
Previous 17,516
0.26%
Holding current value
$4.01 Million
Previous $3.25 Million
25.07%
% of portfolio
0.71%
Previous 0.61%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
4,375Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.52 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $403B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...